| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Rheumatology & Inflammation Research, Göteborg University, Guldhedsgatan 10A, 413 46 Göteborg, Sweden
2 Department of Virology, Göteborg University, Guldhedsgatan 10A, 413 46 Göteborg, Sweden
3 Department of Dermatovenereology, Göteborg University, Guldhedsgatan 10A, 413 46 Göteborg, Sweden
4 Department of Dermatology, Uddevalla Hospital, Uddevalla, Sweden
Correspondence
Kristina Eriksson
kristina.eriksson{at}microbio.gu.se
T-cell recognition of the secreted and membrane-bound portions of the herpes simplex virus type 2 (HSV-2) glycoprotein G (sgG-2 and mgG-2, respectively) was compared in symptomatic and asymptomatic HSV-2-infected individuals and in HSV-2-seronegative controls and the responses with HSV-1 glycoproteins C and E (gC-1 and gE-1) were compared. CD4+ T cells from HSV-2-infected individuals specifically recognized both sgG-2 and mgG-2, whereas HSV-1-infected and HSV-seronegative controls did not respond to these glycoproteins. The responses to gC-1 and gE-1, on the other hand, were not type specific, as blood mononuclear cells from both HSV-1- and HSV-2-infected individuals responded in vitro. There was an association between the status of the infection (symptomatic versus asymptomatic) and the CD4+ T-cell responsiveness. Symptomatic HSV-2-seropositive individuals responded with significantly lower Th1 cytokine production to sgG-2 and mgG-2 than did asymptomatic HSV-2-infected carriers, especially within the HSV-1-negative cohort. No differences in T-cell proliferation were observed between asymptomatic and symptomatic individuals. The results have implications for studies of HSV-2-specific CD4+ T-cell reactivity in general and for analysis of immunological differences between asymptomatic and symptomatic individuals in particular.
These authors contributed equally to this work.
This article has been cited by other articles:
|
|
 |
|
  A. A. Chentoufi, N. R. Binder, N. Berka, G. Durand, A. Nguyen, I. Bettahi, B. Maillere, and L. BenMohamed Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B J. Virol., December 1, 2008; 82(23): 11792 - 11802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Svensson, A.-M. H. Bergin, G.-B. Lowhagen, P. Tunback, L. Bellner, L. Padyukov, and K. Eriksson A 3'-untranslated region polymorphism in the TBX21 gene encoding T-bet is a risk factor for genital herpes simplex virus type 2 infection in humans J. Gen. Virol., September 1, 2008; 89(9): 2262 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Svensson, J. Kaim, C. Mallard, A. Olsson, E. Brodin, T. Hokfelt, and K. Eriksson Neurokinin 1 Receptor Signaling Affects the Local Innate Immune Defense against Genital Herpes Virus Infection J. Immunol., November 15, 2005; 175(10): 6802 - 6811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Svensson, I. Nordstrom, J.-B. Sun, and K. Eriksson Protective Immunity to Genital Herpes Simpex Virus Type 2 Infection Is Mediated by T-bet J. Immunol., May 15, 2005; 174(10): 6266 - 6273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bellner, F. Thoren, E. Nygren, J.-A. Liljeqvist, A. Karlsson, and K. Eriksson A Proinflammatory Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Affects Neutrophil, Monocyte, and NK Cell Functions J. Immunol., February 15, 2005; 174(4): 2235 - 2241. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
